Purpose: We compare the intermediate-term outcome of initial trabeculectomy with adjunctive mitomycin C use versus initial trabeculectomy alone for juvenile primary open-angle glaucoma. Methods: This retrospective consecutive analysis included 44 eyes from 36 patients with juvenile primary-open angle glaucoma, all of whom underwent either initial trabeculectomy with adjunctive mitomycin C use (15 eyes) or initial trabeculectomy alone without mitomycin C use (29 eyes). We compared the success rate and complications between the two groups in a three-year follow-up period following surgery. Results: Three years subsequent to surgery, the cumulative success probability was 73% for the mitomycin C group and 68% for the control group, there being no real difference between the two groups (p = 0.89). A greater incidence of hypotony maculopathy was found amongst the mitomycin C group than was the case for the control group (20 versus 0%, respectively, p = 0.034). A lower intraocular pressure amongst the mitomycin C group was noted as compared with the control group (10.8 ± 3.0 versus 13.3 ± 3.8 mm Hg, respectively, p = 0.017) amongst the successfully treated patients. Conclusions: Despite the lower intraocular pressure level for the successfully treated patients from the trabeculectomy with mitomycin C group, and a greater incidence of resultant hypotony maculopathy for this group as compared with the trabeculectomy alone group, there appeared to be no significant difference in the cumulative success probability for this group as compared with the trabeculectomy alone group. Therefore, we caution against the use of an initial trabeculectomy with mitomycin C for juvenile primary open-angle glaucoma.

Keywords:
Trabeculectomy, Mitomycin C, Juvenile primary open-angle glaucoma, Hypotony maculopathy
1.
Cairns JE: Trabeculectomy: Preliminary report of a new method. Am J Ophthalmol 1968;66:673–679.
2.
Gressel MG, Heuer DK, Parrish RK 2nd: Trabeculectomy in young patients. Ophthalmology 1984;91:1242–1246.
3.
Costa VP, Jay KL, Spaeth GL, Smith M, Gandham S: Primary trabeculectomy in young adults. Ophthalmology 1993;100:1071–1076.
4.
Michel JW, Liebmann JM, Ritch R: Initial 5-fluorouracil trabeculectomy in young patients. Ophthalmology 1992;99:7–13.
5.
Parrish RK 2nd, Folberg R: Wound healing in glaucoma; in Ritsch R, Shield MB, Krupin T (eds): The Glaucomas. St Louis, Mosby, 1996, pp 1633–1651.
6.
Chen CW, Huang HT, Bair JS, Lee CC: Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma. J Ocular Pharmacology 1990;6:175–182.
7.
Beck AD, Wilson WR, Lynch MG, Lynn MJ, Noe R: Trabeculectomy with adjunctive mitomycin C in pediatric glaucoma. Am J Ophthalmol 1998;126:648–657.
8.
Cheung JC, Wright MM, Murali S, Pederson JE: Intermediate-term outcome of variable dose mitomycin C filtering surgery. Ophthalmology 1997;104:143–149.
9.
Kitazawa Y, Hiromi SM, Yamamoto T, Kawase K: Low-dose and high-dose mitomycin trabeculectomy as an initial surgery in primary open-angle glaucoma. Ophthalmology 1993;100:1624–1628.
10.
The Primary Trabeculectomy Antimetabolite Study Group: Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil. Ophthalmology 2000;107:2305–2309.
11.
Skuta GL, Beeson CC, Higginbotham EJ, Lichter PR, Musch DC, Bergstrom TJ, Klein TB, Falck FY Jr: Intraoperative mitomycin C versus postoperative 5-fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology 1992;99:438–444.
12.
Stamper RL, McMenemy MG, Lieberman MF: Hypotonus maculopathy after trabeculectomy with subconjunctival 5-fluorouracil. Am J Ophthalmol 1992;114:544–553.
13.
Mietz H, Raschka B, Krieglstein GK: Risk factors for failures of trabeculectomies performed without antimetabolites. Br J Ophthalmol 1999;83:814–821.
14.
The Fluorouracil Filtering Surgery Study Group: Three-year follow-up of the fluorouracil filtering surgery study. Am J Ophthalmol 1993;115:82–92.
15.
Kitazawa Y, Kawase K, Matsushita H, Minobe M: Trabeculectomy with mitomycin. A comparative study with fluorouracil. Arch Ophthalmol 1991;109:1693–1698.
16.
Megevand GS, Salmon JF, Scholtz RP, Murray AN: The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery. Ophthalmology 1995;102:84–90.
17.
Suner IJ, Greenfield DS, Miller MP, Nicolela MT, Palmberg PF: Hypotony maculopathy after filtering surgery with mitomycin C. Ophthalmology 1997;104:207–215.
18.
Reichert R, Stewart W, Shields MB: Limbus-based versus fornix-based conjunctival flaps in trabeculectomy. Ophthalmic Surg 1987;18:672–676.
19.
Traverso CE, Tomey KF, Antonios S: Limbal-vs fornix-based conjunctival trabeculectomy flaps. Am J Ophthalmol 1987;104:28–32.
20.
Brincker P, Kressing SV: Limbus-based versus fornix-based conjunctival flap in glaucoma filtering surgery. Acta Ophthalmol 1992;70:641–644.
21.
Akkimoto M, Tanihara H, Negi A, Nagata M: Surgical results of trabeculotomy ab externo for developmental glaucoma. Arch Ophthalmol 1994;112:1540–1544.
22.
Groh MJ, Behrens A, Handel A, Kuchle M: Mid- and long-term results after trabeculectomy in patients with juvenile and late-juvenile open-angle glaucoma (German). Klin Monatsbl Augenheilkd 2000;217:71–76
23.
Luntz MH, Livingston DG: Trabeculotomy ab externo and trabeculectomy in congenital and adult-onset glaucoma. Am J Ophthalmol 1977;83:174–179.
24.
Schwenn O, Kersten I, Dick HB, Muller H, Pfeiffer N: Effect of early postfiltration ocular hypotony on visual acuity, long-term intraocular pressure control, and posterior segment morphology. J Glaucoma 2001;10:85–88.
25.
Siegfried CJ, Rosenberg LF, Krupin T, Jampol LM: Hypotony after glaucoma filtering surgery: Mechanics and incidence. J Glaucoma 1995;4:63–69.
26.
Hoskins HD Jr, Kass MA: Developmental and childhood glaucoma; in Hoskins HD Jr, Kass MA (eds): Becker-Shaffer’s Diagnosis and Therapy of the Glaucomas. St Louis, Mosby, 1989, pp 364–365.
27.
Melamed S, Ashkezazi: Juvenile-onset open angle glaucoma; in Abert DM, Jakobic FA (eds): Principles and Practice of Ophthalmology. Philadelphia, WB Saunders, 1994, pp 1345–1349.
28.
Dickens CJ, Hoskins HD Jr: Epidemiology and pathophysiology of congenital glaucoma; in Ritch R, Shields MB, Krupin T (eds): The Glaucomas. St Louis, Mosby, 1996, pp 729–738.
29.
D’Ermo F, Bonomi L, Doro D: A critical analysis of the long-term results of trabeculectomy. Am J Ophthalmol 1979;88:829–835.
30.
Richter CJ, Shingleton BJ, Bellows AR, Hutchinson BT, O’Connor, Brill I: The development of encapsulated filtering blebs. Ophthalmology 1988;95:1163–1168.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.